ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,310.40
-0.20%
S&P ASX All Technology
3,765.60
-0.15%
Brent Oil
79.93
-0.73%
US Dollar vs AUD
1.61275
0.16%
Bitcoin
105,238.25
5.23%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Sanofi (SNW) Share Price

Sanofi

Sanofi (SNW)

TG
98.19
-0.25
( -0.25% )
Updated: 06:35:01
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
98.19
Bid
98.21
Offer
98.35
Volume
9,988
98.00 Day's Range 100.08
84.94 52 Week Range 106.12
Market Cap
122.997B
Previous Close
98.44
Open
98.59
Last Trade
40
@
98.19
Last Trade Time
05:53:55
Financial Volume
-
VWAP
-
Average Volume (3m)
5,685
Shares Outstanding
1,252,640,466
Dividend Yield
3.83%
PE Ratio
22.78
Earnings Per Share (EPS)
4.31
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
www.sanofi.com
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Tradegate (DE) with ticker SNW. The last closing price for Sanofi was 98.44 €. Over the last year, Sanofi shares have traded in a share price range of 84.94 € to 106.12 €.

Sanofi currently has 1,252,640,466 shares in issue. The market capitalisation of Sanofi is 123.31 € billion. Sanofi has a price to earnings ratio (PE ratio) of 22.78.

Ask ADVFN Intelligence (AI)

SNW Latest News

More News

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II...

16 January 2025
UK Regulatory

Sanofi: Information concerning the total number of voting rights and shares – November 2024

Sanofi: Information concerning the total number of voting rights and shares – November 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

16 January 2025
UK Regulatory

Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma Sarclisa obtains first approval in China for the treatment...

13 January 2025
UK Regulatory

Communiqué de presse : Sarclisa : première approbation en Chine pour le traitement du myélome multiple en rechute ou réfractaire de l’adulte

Communiqué de presse : Sarclisa : première approbation en Chine pour le traitement du myélome multiple en rechute ou réfractaire de l’adulte Sarclisa : première approbation en Chine pour le...

13 January 2025
UK Regulatory

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

09 January 2025
UK Regulatory

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

09 January 2025
UK Regulatory

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

23 December 2024
UK Regulatory

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

23 December 2024
UK Regulatory

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

20 December 2024
UK Regulatory

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

20 December 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.052.1323070522296.14100.0893.1403595.93084754DE
46.977.6408682306591.22100.0889.94430494.46700245DE
12-0.81-0.81818181818299102.9887.64568593.31924813DE
266.186.7166612324792.01106.1287.64535196.86894609DE
524.234.5019157088193.96106.1284.94591792.78850622DE
1566.697.3114754098491.5106.4676.52515992.18825094DE
2606.356.9141986062791.84106.4667.79810087.34905347DE

SNW - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 98.19 €
How many Sanofi shares are in issue?
Sanofi has 1,252,640,466 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 123.31B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 84.94 € to 106.12 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 22.78
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 2.86
What is the reporting currency for Sanofi?
Sanofi reports financial results in EUR
What is the latest annual turnover for Sanofi?
The latest annual turnover of Sanofi is EUR 43.07B
What is the latest annual profit for Sanofi?
The latest annual profit of Sanofi is EUR 5.4B
What is the registered address of Sanofi?
The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
N86Nukkleus Inc
31.22 €
(51.26%)
15.18k
VOPInvestigator Resources Ltd
0.0225 €
(50.00%)
36.24k
42FBAIML Innovations Inc
0.1035 €
(35.83%)
1.32k
BICBTCS Inc
3.41 €
(30.65%)
16.78k
4OYForsee Power SA
0.662 €
(28.54%)
200
PU11Social Chain AG
0.0106 €
(-50.47%)
23.15k
K1SNKlondike Silver Corporation
0.006 €
(-42.86%)
2.5k
7BLBlue Lagoon Resources Inc
0.0642 €
(-30.67%)
868
L7C2Windfall Geotek Inc
0.006 €
(-29.41%)
2.27k
LN00Cult Food Science Corp
0.0264 €
(-25.84%)
32k
D7GNel ASA
0.1907 €
(0.10%)
4.89M
POQ88 Energy Limited
0.0013 €
(8.33%)
2.35M
PLUNPlug Power Inc
2.4255 €
(-8.99%)
2.3M
3CPXiaomi Corporation
4.4045 €
(3.39%)
1.51M
RQ0DWave Quantum Inc
5.198 €
(-7.74%)
1.48M

Discussion

View Full Feed
BRoberts1982 BRoberts1982 2 minutes ago
The guy has ZERO Shame.

valleybenedetto
Re: BRoberts1982 post# 26007

Tuesday, March 05, 2024 9:44:12 AM
Post# of 31211
There are no delays. I expect WV to fund this week. Thank you.
CLNV
ducci1 ducci1 2 minutes ago
VIX LITS Still S1 15.96 ?
SPY
vlispxpert vlispxpert 3 minutes ago
MATV 9.57 bids filling, doubled, new #1...it's a LONG for me...good luck!
Eagle1 Eagle1 3 minutes ago
Thanks for your Advice here. Are you an advisor? Tell me about the


XRP?
GDVM
al44 al44 3 minutes ago
Welcome aboard-

https://media.gettr.com/group4/getter/2025/01/17/00/2476e788-49cc-f962-eb7b-b90866baea30/254d86f1325eaac2c56e8601a89f88f3_768x0.jpg
loyalinvestor1212 loyalinvestor1212 3 minutes ago
For years this stock has gone up to $15 and down to the $3’s. This is theft and if you still own this stock, your investment strategy..well sucks. You are trading on pure smoke and mirrors.
AVXL
Triple nickle Triple nickle 3 minutes ago
Still adding 
AREN
loyalinvestor1212 loyalinvestor1212 4 minutes ago
For years this stock has up $15 and down to the $3’s. This is theft and if you still own this stock, your investment strategy..well sucks. You are trading on pure smoke and mirrors.
AVXL
glenn1919 glenn1919 4 minutes ago
SNAL......................................https://stockcharts.com/h-sc/ui?s=SNAL&p=W&b=5&g=0&id=p86431144783
SNAL
Backstabbed Backstabbed 4 minutes ago
It's as real as your stupidity! Go $TRII
TRII
Docsavag Docsavag 4 minutes ago
Interesting...
RIGATONI RIGATONI 4 minutes ago
.046s hitting with heavy buying ~Rig
marylandstockguy marylandstockguy 4 minutes ago
Looks like a scant few are getting quad 5s too....that's kind of a temptation of putting in a limit order of trip 1 - you might get lucky
GTCH
$Money Bags$ $Money Bags$ 4 minutes ago
I'm not sure it would be insiders loading, but someone believes this is heading north.  I'm all for that regardless of whether he's talking or not.  It's like betting on one horse to win and another to show.  
UATG
jeunke22 jeunke22 4 minutes ago
From the list you provided, the companies that design their own optical engines for transceivers are:
- Innolight : Known for its high-speed optical transceivers, InnoLight designs and manufactures its own optical engines.
- Cisco (Acacia): Cisco, through its acquisition of Acacia, des
LWLG
Tdeank1 Tdeank1 5 minutes ago
Well 5% on the dollar is historical

I'm hoping for 8%

2 dollars per k
COOP
theroc66 theroc66 5 minutes ago
Exactly Pro. Not to mention the ease of incorporating polymers in the foundries processes vs other materials!

GLTAL
AR.
LWLG
bucks2pennies bucks2pennies 5 minutes ago
I guess .0002 was the run we were all waiting for.
GTCH
Seminole Red Seminole Red 5 minutes ago
us that at draft kings
crazy horse 0 crazy horse 0 5 minutes ago
Mugshot released of man accused of injuring deputy then leading multi-county chase

https://winknews.com/2025/01/17/mugshot-released-of-man-accused-of-injuring-deputy-then-leading-multi-county-chase/
scoobey-do scoobey-do 5 minutes ago
ARway.ai CEO Acquires 3.7Mill+ Shares!

ARway.ai Fri, Jan 17, 2025 at 11:40 AM
A Message to Our Investors: Confidence in the Vision, Aligned with the Future

Dear Valued Investors,

I want to share a significant upda
ARWYF
EmpressMonk25 EmpressMonk25 5 minutes ago
This statement is an exaggeration... “When they started selling off every aspect of business”

The acquisition and sale of some parts of the business, excluding the sale of Humbl Financial, were acquisitions of alternative solutions amid the four-year regulatory threats by Gensler & C
HMBL
valleybenedetto valleybenedetto 5 minutes ago
Moving up a bit. Maybe Africa has been discovered by Holcomb
ASRE

Your Recent History

TG
SNW
Sanofi
BIT
NSCITOTENOE2
Portugal Republik
CSE
NT
Newterra Resources
BIT
NSCIT0052174
Italian Republic
GATE
IOENUSDT
Internet of Energy Network
AMEX
QLTY
GMO US Quality ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads